ID   OAT_HUMAN               Reviewed;         439 AA.
AC   P04181; D3DRF0; Q16068; Q16069; Q68CS0; Q6IAV9; Q9UD03;
DT   20-MAR-1987, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-1987, sequence version 1.
DT   10-MAY-2017, entry version 198.
DE   RecName: Full=Ornithine aminotransferase, mitochondrial;
DE            EC=2.6.1.13;
DE   AltName: Full=Ornithine delta-aminotransferase;
DE   AltName: Full=Ornithine--oxo-acid aminotransferase;
DE   Contains:
DE     RecName: Full=Ornithine aminotransferase, hepatic form;
DE   Contains:
DE     RecName: Full=Ornithine aminotransferase, renal form;
DE   Flags: Precursor;
GN   Name=OAT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3456579; DOI=10.1073/pnas.83.5.1203;
RA   Inana G., Totsuka S., Redmond M., Dougherty T., Nagle J., Shiono T.,
RA   Ohura T., Kominami E., Katunuma N.;
RT   "Molecular cloning of human ornithine aminotransferase mRNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:1203-1207(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=3816496; DOI=10.1089/dna.1.1986.5.493;
RA   Ramesh V., Shaffer M.M., Allaire J.M., Shih V.E., Gusella J.F.;
RT   "Investigation of gyrate atrophy using a cDNA clone for human
RT   ornithine aminotransferase.";
RL   DNA 5:493-501(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 36-40, AND
RP   PROTEOLYTIC PROCESSING.
RC   TISSUE=Kidney;
RX   PubMed=2507357; DOI=10.1016/0014-5793(89)81110-X;
RA   Kobayashi T., Nishii M., Takagi Y., Titani T., Matsuzawa T.;
RT   "Molecular cloning and nucleotide sequence analysis of mRNA for human
RT   kidney ornithine aminotransferase. An examination of ornithine
RT   aminotransferase isozymes between liver and kidney.";
RL   FEBS Lett. 255:300-304(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=3170546;
RA   Mitchell G.A., Looney J.E., Brody L.C., Steel G., Suchanek M.,
RA   Engelhardt J.F., Willard H.F., Valle D.;
RT   "Human ornithine-delta-aminotransferase. cDNA cloning and analysis of
RT   the structural gene.";
RL   J. Biol. Chem. 263:14288-14295(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=2373169; DOI=10.1016/0014-4835(90)90126-F;
RA   Zintz C.B., Inana G.;
RT   "Analysis of the human ornithine aminotransferase gene family.";
RL   Exp. Eye Res. 50:759-770(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Brain cortex, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain cortex;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 50-58 AND 328-336 (ISOFORM 1).
RX   PubMed=1682785;
RA   Ramesh V., Gusella J.F., Shih V.E.;
RT   "Molecular pathology of gyrate atrophy of the choroid and retina due
RT   to ornithine aminotransferase deficiency.";
RL   Mol. Biol. Med. 8:81-93(1991).
RN   [13]
RP   PARTIAL PROTEIN SEQUENCE, PYRIDOXAL PHOSPHATE AT LYS-292, AND
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=3754226; DOI=10.1016/0014-5793(86)81219-4;
RA   Simmaco M., John R.A., Barra D., Bossa F.;
RT   "The primary structure of ornithine aminotransferase. Identification
RT   of active-site sequence and site of post-translational proteolysis.";
RL   FEBS Lett. 199:39-42(1986).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=9309222; DOI=10.1016/S0969-2126(97)00258-X;
RA   Shah S.A., Shen B.W., Brunger A.T.;
RT   "Human ornithine aminotransferase complexed with L-canaline and
RT   gabaculine: structural basis for substrate recognition.";
RL   Structure 5:1067-1075(1997).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS), AND COFACTOR.
RX   PubMed=9514741; DOI=10.1006/jmbi.1997.1583;
RA   Shen B.W., Hennig M., Hohenester E., Jansonius J.N., Schirmer T.;
RT   "Crystal structure of human recombinant ornithine aminotransferase.";
RL   J. Mol. Biol. 277:81-102(1998).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS).
RX   PubMed=9878407; DOI=10.1006/jmbi.1998.2289;
RA   Storici P., Capitani G., Mueller R., Schirmer T., Jansonius J.N.;
RT   "Crystal structure of human ornithine aminotransferase complexed with
RT   the highly specific and potent inhibitor 5-fluoromethylornithine.";
RL   J. Mol. Biol. 285:297-309(1999).
RN   [20]
RP   VARIANTS HOGA LYS-54 AND MET-332.
RX   PubMed=3375240; DOI=10.1073/pnas.85.11.3777;
RA   Ramesh V., McClatchey A.I., Ramesh N., Benoit L.A., Berson E.L.,
RA   Shih V.E., Gusella J.F.;
RT   "Molecular basis of ornithine aminotransferase deficiency in B-6-
RT   responsive and -nonresponsive forms of gyrate atrophy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:3777-3780(1988).
RN   [21]
RP   VARIANT HOGA TYR-319.
RX   PubMed=2793865;
RA   Inana G., Chambers C., Hotta Y., Inouye L., Filpula D., Pulford S.,
RA   Shiono T.;
RT   "Point mutation affecting processing of the ornithine aminotransferase
RT   precursor protein in gyrate atrophy.";
RL   J. Biol. Chem. 264:17432-17436(1989).
RN   [22]
RP   VARIANTS HOGA THR-180; LEU-241; PRO-250; ASP-353 AND ARG-394.
RX   PubMed=1612597; DOI=10.1016/0888-7543(92)90258-T;
RA   Michaud J., Brody L.C., Steel G., Fontaine G., Martin L.S., Valle D.,
RA   Mitchell G.;
RT   "Strand-separating conformational polymorphism analysis: efficacy of
RT   detection of point mutations in the human ornithine delta-
RT   aminotransferase gene.";
RL   Genomics 13:389-394(1992).
RN   [23]
RP   VARIANTS HOGA HIS-55; LYS-89; PHE-93; LEU-154; THR-180; ALA-184 DEL;
RP   LEU-241; CYS-245; PRO-250; ILE-267; LYS-271; ASP-353; ALA-375;
RP   ARG-394; PRO-402 AND LEU-417, AND VARIANT PHE-437.
RX   PubMed=1737786;
RA   Brody L.C., Mitchell G.A., Obie C., Michaud J., Steel G., Fontaine G.,
RA   Robert M.-F., Sipila I., Kaiser-Kupfer M., Valle D.;
RT   "Ornithine delta-aminotransferase mutations in gyrate atrophy. Allelic
RT   heterogeneity and functional consequences.";
RL   J. Biol. Chem. 267:3302-3307(1992).
RN   [24]
RP   VARIANT HOGA VAL-226.
RX   PubMed=7887415;
RA   Michaud J., Thompson G.N., Brody L.C., Steel G., Obie C., Fontaine G.,
RA   Schappert K., Keith C.G., Valle D., Mitchell G.A.;
RT   "Pyridoxine-responsive gyrate atrophy of the choroid and retina:
RT   clinical and biochemical correlates of the mutation A226V.";
RL   Am. J. Hum. Genet. 56:616-622(1995).
RN   [25]
RP   VARIANT HOGA GLU-90.
RX   PubMed=7668253;
RA   Kobayashi T., Ogawa H., Kasahara M., Shiozawa Z., Matsuzawa T.;
RT   "A single amino acid substitution within the mature sequence of
RT   ornithine aminotransferase obstructs mitochondrial entry of the
RT   precursor.";
RL   Am. J. Hum. Genet. 57:284-291(1995).
RN   [26]
RP   VARIANTS HOGA ASP-51; ARG-104; GLN-199; LYS-318; MET-332; TYR-394;
RP   LEU-417; ASN-436 AND PHE-437, CHARACTERIZATION OF ASP-51; ARG-104;
RP   GLN-199; VAL-226; LYS-318; MET-332; TYR-394; LEU-402; LEU-417; ASN-436
RP   AND PHE-437, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=23076989; DOI=10.1002/humu.22233;
RA   Doimo M., Desbats M.A., Baldoin M.C., Lenzini E., Basso G., Murphy E.,
RA   Graziano C., Seri M., Burlina A., Sartori G., Trevisson E.,
RA   Salviati L.;
RT   "Functional analysis of missense mutations of OAT, causing gyrate
RT   atrophy of choroid and retina.";
RL   Hum. Mutat. 34:229-236(2013).
CC   -!- CATALYTIC ACTIVITY: L-ornithine + a 2-oxo acid = L-glutamate 5-
CC       semialdehyde + an L-amino acid.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:9514741};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-proline biosynthesis; L-
CC       glutamate 5-semialdehyde from L-ornithine: step 1/1.
CC   -!- SUBUNIT: Homohexamer. {ECO:0000269|PubMed:23076989}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:23076989}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P04181-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P04181-2; Sequence=VSP_043085;
CC   -!- DISEASE: Hyperornithinemia with gyrate atrophy of choroid and
CC       retina (HOGA) [MIM:258870]: A disorder clinically characterized by
CC       a triad of progressive chorioretinal degeneration, early cataract
CC       formation, and type II muscle fiber atrophy. Characteristic
CC       chorioretinal atrophy with progressive constriction of the visual
CC       fields leads to blindness at the latest during the sixth decade of
CC       life. Patients generally have normal intelligence.
CC       {ECO:0000269|PubMed:1612597, ECO:0000269|PubMed:1737786,
CC       ECO:0000269|PubMed:23076989, ECO:0000269|PubMed:2793865,
CC       ECO:0000269|PubMed:3375240, ECO:0000269|PubMed:7668253,
CC       ECO:0000269|PubMed:7887415}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-III pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M12267; AAA59956.1; -; mRNA.
DR   EMBL; M14963; AAA59959.1; -; mRNA.
DR   EMBL; Y07511; CAA68809.1; -; mRNA.
DR   EMBL; M23204; AAA36386.1; -; mRNA.
DR   EMBL; M23205; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; M88760; AAA59958.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; M29927; AAA59957.1; -; Genomic_DNA.
DR   EMBL; M29919; AAA59957.1; JOINED; Genomic_DNA.
DR   EMBL; M29920; AAA59957.1; JOINED; Genomic_DNA.
DR   EMBL; M29921; AAA59957.1; JOINED; Genomic_DNA.
DR   EMBL; M29922; AAA59957.1; JOINED; Genomic_DNA.
DR   EMBL; M29923; AAA59957.1; JOINED; Genomic_DNA.
DR   EMBL; M29924; AAA59957.1; JOINED; Genomic_DNA.
DR   EMBL; M29925; AAA59957.1; JOINED; Genomic_DNA.
DR   EMBL; M29926; AAA59957.1; JOINED; Genomic_DNA.
DR   EMBL; AK296032; BAH12241.1; -; mRNA.
DR   EMBL; AK312561; BAG35458.1; -; mRNA.
DR   EMBL; AK315947; BAH14318.1; -; mRNA.
DR   EMBL; CR457045; CAG33326.1; -; mRNA.
DR   EMBL; CR749808; CAH18668.1; -; mRNA.
DR   EMBL; AL445237; CAI17293.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49271.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49272.1; -; Genomic_DNA.
DR   EMBL; BC000964; AAH00964.1; -; mRNA.
DR   EMBL; BC016928; AAH16928.1; -; mRNA.
DR   EMBL; S66418; AAB20298.1; -; mRNA.
DR   EMBL; S66421; AAB20297.1; -; mRNA.
DR   CCDS; CCDS53586.1; -. [P04181-2]
DR   CCDS; CCDS7639.1; -. [P04181-1]
DR   PIR; A30806; XNHUO.
DR   PIR; I55360; I55360.
DR   RefSeq; NP_000265.1; NM_000274.3. [P04181-1]
DR   RefSeq; NP_001165285.1; NM_001171814.1. [P04181-2]
DR   RefSeq; NP_001309894.1; NM_001322965.1. [P04181-1]
DR   RefSeq; NP_001309895.1; NM_001322966.1. [P04181-1]
DR   RefSeq; NP_001309896.1; NM_001322967.1. [P04181-1]
DR   RefSeq; NP_001309897.1; NM_001322968.1. [P04181-1]
DR   RefSeq; NP_001309898.1; NM_001322969.1. [P04181-1]
DR   RefSeq; NP_001309899.1; NM_001322970.1. [P04181-1]
DR   RefSeq; NP_001309900.1; NM_001322971.1.
DR   UniGene; Hs.523332; -.
DR   PDB; 1GBN; X-ray; 2.30 A; A/B/C=38-439.
DR   PDB; 1OAT; X-ray; 2.50 A; A/B/C=1-439.
DR   PDB; 2BYJ; X-ray; 3.02 A; A/B/C=1-439.
DR   PDB; 2BYL; X-ray; 2.15 A; A/B/C=1-439.
DR   PDB; 2CAN; X-ray; 2.30 A; A/B/C=38-439.
DR   PDB; 2OAT; X-ray; 1.95 A; A/B/C=1-439.
DR   PDBsum; 1GBN; -.
DR   PDBsum; 1OAT; -.
DR   PDBsum; 2BYJ; -.
DR   PDBsum; 2BYL; -.
DR   PDBsum; 2CAN; -.
DR   PDBsum; 2OAT; -.
DR   ProteinModelPortal; P04181; -.
DR   SMR; P04181; -.
DR   BioGrid; 110996; 39.
DR   IntAct; P04181; 13.
DR   MINT; MINT-1387274; -.
DR   STRING; 9606.ENSP00000357838; -.
DR   BindingDB; P04181; -.
DR   ChEMBL; CHEMBL5954; -.
DR   DrugBank; DB02821; Canaline.
DR   DrugBank; DB02054; Gabaculine.
DR   DrugBank; DB00129; L-Ornithine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   iPTMnet; P04181; -.
DR   PhosphoSitePlus; P04181; -.
DR   SwissPalm; P04181; -.
DR   BioMuta; OAT; -.
DR   DMDM; 129018; -.
DR   REPRODUCTION-2DPAGE; IPI00022334; -.
DR   EPD; P04181; -.
DR   MaxQB; P04181; -.
DR   PaxDb; P04181; -.
DR   PeptideAtlas; P04181; -.
DR   PRIDE; P04181; -.
DR   DNASU; 4942; -.
DR   Ensembl; ENST00000368845; ENSP00000357838; ENSG00000065154. [P04181-1]
DR   Ensembl; ENST00000539214; ENSP00000439042; ENSG00000065154. [P04181-2]
DR   GeneID; 4942; -.
DR   KEGG; hsa:4942; -.
DR   UCSC; uc001lhp.4; human. [P04181-1]
DR   CTD; 4942; -.
DR   DisGeNET; 4942; -.
DR   GeneCards; OAT; -.
DR   HGNC; HGNC:8091; OAT.
DR   HPA; CAB033576; -.
DR   HPA; HPA040098; -.
DR   HPA; HPA064742; -.
DR   MalaCards; OAT; -.
DR   MIM; 258870; phenotype.
DR   MIM; 613349; gene.
DR   neXtProt; NX_P04181; -.
DR   OpenTargets; ENSG00000065154; -.
DR   Orphanet; 414; Gyrate atrophy of choroid and retina.
DR   PharmGKB; PA31880; -.
DR   eggNOG; KOG1402; Eukaryota.
DR   eggNOG; COG4992; LUCA.
DR   GeneTree; ENSGT00630000089895; -.
DR   HOGENOM; HOG000020206; -.
DR   HOVERGEN; HBG000434; -.
DR   InParanoid; P04181; -.
DR   KO; K00819; -.
DR   OMA; THDHTIR; -.
DR   OrthoDB; EOG091G06WM; -.
DR   PhylomeDB; P04181; -.
DR   TreeFam; TF105720; -.
DR   BioCyc; MetaCyc:HS00832-MONOMER; -.
DR   BRENDA; 2.6.1.13; 2681.
DR   Reactome; R-HSA-70614; Amino acid synthesis and interconversion (transamination).
DR   SABIO-RK; P04181; -.
DR   UniPathway; UPA00098; UER00358.
DR   EvolutionaryTrace; P04181; -.
DR   GenomeRNAi; 4942; -.
DR   PRO; PR:P04181; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000065154; -.
DR   CleanEx; HS_OAT; -.
DR   ExpressionAtlas; P04181; baseline and differential.
DR   Genevisible; P04181; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0042802; F:identical protein binding; IBA:GO_Central.
DR   GO; GO:0004587; F:ornithine-oxo-acid transaminase activity; EXP:Reactome.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IBA:GO_Central.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0055129; P:L-proline biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0034214; P:protein hexamerization; IDA:UniProtKB.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00610; OAT_like; 1.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 2.
DR   InterPro; IPR005814; Aminotrans_3.
DR   InterPro; IPR010164; Orn_aminotrans.
DR   InterPro; IPR034758; Orn_aminotrans_mito.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   PANTHER; PTHR11986:SF100; PTHR11986:SF100; 1.
DR   Pfam; PF00202; Aminotran_3; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   TIGRFAMs; TIGR01885; Orn_aminotrans; 1.
DR   PROSITE; PS00600; AA_TRANSFER_CLASS_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Aminotransferase;
KW   Complete proteome; Direct protein sequencing; Disease mutation;
KW   Mitochondrion; Polymorphism; Pyridoxal phosphate; Reference proteome;
KW   Transferase; Transit peptide.
FT   TRANSIT       1     35       Mitochondrion; in renal form.
FT                                {ECO:0000269|PubMed:2507357}.
FT   TRANSIT       1     25       Mitochondrion; in hepatic form.
FT   CHAIN        26    439       Ornithine aminotransferase, hepatic form.
FT                                /FTId=PRO_0000001262.
FT   CHAIN        36    439       Ornithine aminotransferase, renal form.
FT                                /FTId=PRO_0000001263.
FT   MOD_RES      49     49       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES      66     66       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES     102    102       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES     107    107       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES     107    107       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES     292    292       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000269|PubMed:3754226}.
FT   MOD_RES     362    362       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES     362    362       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES     386    386       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES     392    392       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES     405    405       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES     405    405       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   MOD_RES     421    421       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P29758}.
FT   VAR_SEQ       1    138       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_043085.
FT   VARIANT      51     51       G -> D (in HOGA; loss of activity and
FT                                protein stability; dbSNP:rs11553554).
FT                                {ECO:0000269|PubMed:23076989}.
FT                                /FTId=VAR_071924.
FT   VARIANT      54     54       N -> K (in HOGA; dbSNP:rs121965048).
FT                                {ECO:0000269|PubMed:3375240}.
FT                                /FTId=VAR_000565.
FT   VARIANT      55     55       Y -> H (in HOGA; dbSNP:rs121965037).
FT                                {ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000566.
FT   VARIANT      89     89       N -> K (in HOGA; dbSNP:rs386833602).
FT                                {ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000567.
FT   VARIANT      90     90       Q -> E (in HOGA; mistargeted, accumulates
FT                                in cytoplasm; dbSNP:rs121965060).
FT                                {ECO:0000269|PubMed:7668253}.
FT                                /FTId=VAR_015648.
FT   VARIANT      93     93       C -> F (in HOGA; dbSNP:rs121965038).
FT                                {ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000568.
FT   VARIANT     104    104       Q -> R (in HOGA; loss of activity and
FT                                protein stability; dbSNP:rs386833604).
FT                                {ECO:0000269|PubMed:23076989}.
FT                                /FTId=VAR_071925.
FT   VARIANT     154    154       R -> L (in HOGA; complete loss of
FT                                activity; dbSNP:rs121965039).
FT                                {ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000569.
FT   VARIANT     180    180       R -> T (in HOGA; complete loss of
FT                                activity; dbSNP:rs121965040).
FT                                {ECO:0000269|PubMed:1612597,
FT                                ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000570.
FT   VARIANT     184    184       Missing (in HOGA).
FT                                {ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000571.
FT   VARIANT     199    199       P -> Q (in HOGA; loss of activity and
FT                                protein stability; dbSNP:rs267606925).
FT                                {ECO:0000269|PubMed:23076989}.
FT                                /FTId=VAR_071926.
FT   VARIANT     226    226       A -> V (in HOGA; loss of activity and
FT                                protein stability; dbSNP:rs121965059).
FT                                {ECO:0000269|PubMed:23076989,
FT                                ECO:0000269|PubMed:7887415}.
FT                                /FTId=VAR_000572.
FT   VARIANT     241    241       P -> L (in HOGA; dbSNP:rs121965051).
FT                                {ECO:0000269|PubMed:1612597,
FT                                ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000573.
FT   VARIANT     245    245       Y -> C (in HOGA; dbSNP:rs121965046).
FT                                {ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000574.
FT   VARIANT     250    250       R -> P (in HOGA; dbSNP:rs121965052).
FT                                {ECO:0000269|PubMed:1612597,
FT                                ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000575.
FT   VARIANT     267    267       T -> I (in HOGA; dbSNP:rs386833618).
FT                                {ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000576.
FT   VARIANT     270    270       A -> P (in HOGA; dbSNP:rs121965041).
FT                                /FTId=VAR_000577.
FT   VARIANT     271    271       R -> K (in HOGA; dbSNP:rs121965042).
FT                                {ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000578.
FT   VARIANT     318    318       E -> K (in HOGA; loss of activity and
FT                                protein stability; dbSNP:rs386833621).
FT                                {ECO:0000269|PubMed:23076989}.
FT                                /FTId=VAR_071927.
FT   VARIANT     319    319       H -> Y (in HOGA; dbSNP:rs121965049).
FT                                {ECO:0000269|PubMed:2793865}.
FT                                /FTId=VAR_000579.
FT   VARIANT     332    332       V -> M (in HOGA; loss of activity and
FT                                protein stability; dbSNP:rs121965047).
FT                                {ECO:0000269|PubMed:23076989,
FT                                ECO:0000269|PubMed:3375240}.
FT                                /FTId=VAR_000580.
FT   VARIANT     353    353       G -> D (in HOGA; dbSNP:rs121965053).
FT                                {ECO:0000269|PubMed:1612597,
FT                                ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000581.
FT   VARIANT     375    375       G -> A (in HOGA; dbSNP:rs121965045).
FT                                {ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000582.
FT   VARIANT     394    394       C -> R (in HOGA; dbSNP:rs121965054).
FT                                {ECO:0000269|PubMed:1612597,
FT                                ECO:0000269|PubMed:1737786}.
FT                                /FTId=VAR_000583.
FT   VARIANT     394    394       C -> Y (in HOGA; loss of activity and
FT                                protein stability; dbSNP:rs386833597).
FT                                {ECO:0000269|PubMed:23076989}.
FT                                /FTId=VAR_071928.
FT   VARIANT     402    402       L -> P (in HOGA; loss of activity and
FT                                protein stability; dbSNP:rs121965043).
FT                                {ECO:0000269|PubMed:1737786,
FT                                ECO:0000269|PubMed:23076989}.
FT                                /FTId=VAR_000584.
FT   VARIANT     417    417       P -> L (in HOGA; loss of activity and
FT                                protein stability; dbSNP:rs121965044).
FT                                {ECO:0000269|PubMed:1737786,
FT                                ECO:0000269|PubMed:23076989}.
FT                                /FTId=VAR_000585.
FT   VARIANT     436    436       I -> N (in HOGA; loss of activity and
FT                                protein stability; dbSNP:rs386833598).
FT                                {ECO:0000269|PubMed:23076989}.
FT                                /FTId=VAR_071929.
FT   VARIANT     437    437       L -> F (in HOGA; no effect on activity
FT                                and protein stability; dbSNP:rs1800456).
FT                                {ECO:0000269|PubMed:1737786,
FT                                ECO:0000269|PubMed:23076989}.
FT                                /FTId=VAR_000586.
FT   HELIX        40     50       {ECO:0000244|PDB:2OAT}.
FT   STRAND       61     67       {ECO:0000244|PDB:2OAT}.
FT   STRAND       69     72       {ECO:0000244|PDB:2OAT}.
FT   STRAND       77     82       {ECO:0000244|PDB:2OAT}.
FT   HELIX        83     86       {ECO:0000244|PDB:2OAT}.
FT   TURN         87     90       {ECO:0000244|PDB:2OAT}.
FT   HELIX        95    105       {ECO:0000244|PDB:2OAT}.
FT   STRAND      115    119       {ECO:0000244|PDB:2OAT}.
FT   HELIX       120    131       {ECO:0000244|PDB:2OAT}.
FT   STRAND      134    141       {ECO:0000244|PDB:2OAT}.
FT   HELIX       142    159       {ECO:0000244|PDB:2OAT}.
FT   STRAND      169    173       {ECO:0000244|PDB:2OAT}.
FT   HELIX       182    185       {ECO:0000244|PDB:2OAT}.
FT   HELIX       191    194       {ECO:0000244|PDB:2OAT}.
FT   STRAND      204    207       {ECO:0000244|PDB:2OAT}.
FT   HELIX       212    218       {ECO:0000244|PDB:2OAT}.
FT   STRAND      224    229       {ECO:0000244|PDB:2OAT}.
FT   STRAND      231    233       {ECO:0000244|PDB:2OAT}.
FT   TURN        234    237       {ECO:0000244|PDB:2OAT}.
FT   HELIX       245    255       {ECO:0000244|PDB:2OAT}.
FT   STRAND      259    263       {ECO:0000244|PDB:2OAT}.
FT   TURN        265    272       {ECO:0000244|PDB:2OAT}.
FT   STRAND      273    276       {ECO:0000244|PDB:2OAT}.
FT   HELIX       277    281       {ECO:0000244|PDB:2OAT}.
FT   STRAND      286    290       {ECO:0000244|PDB:2OAT}.
FT   HELIX       292    295       {ECO:0000244|PDB:2OAT}.
FT   STRAND      302    306       {ECO:0000244|PDB:2OAT}.
FT   HELIX       308    311       {ECO:0000244|PDB:2OAT}.
FT   HELIX       327    342       {ECO:0000244|PDB:2OAT}.
FT   HELIX       345    360       {ECO:0000244|PDB:2OAT}.
FT   TURN        365    367       {ECO:0000244|PDB:2OAT}.
FT   STRAND      368    374       {ECO:0000244|PDB:2OAT}.
FT   STRAND      377    382       {ECO:0000244|PDB:2OAT}.
FT   HELIX       390    399       {ECO:0000244|PDB:2OAT}.
FT   STRAND      406    414       {ECO:0000244|PDB:2OAT}.
FT   HELIX       422    437       {ECO:0000244|PDB:2OAT}.
SQ   SEQUENCE   439 AA;  48535 MW;  E9D0636824A83220 CRC64;
     MFSKLAHLQR FAVLSRGVHS SVASATSVAT KKTVQGPPTS DDIFEREYKY GAHNYHPLPV
     ALERGKGIYL WDVEGRKYFD FLSSYSAVNQ GHCHPKIVNA LKSQVDKLTL TSRAFYNNVL
     GEYEEYITKL FNYHKVLPMN TGVEAGETAC KLARKWGYTV KGIQKYKAKI VFAAGNFWGR
     TLSAISSSTD PTSYDGFGPF MPGFDIIPYN DLPALERALQ DPNVAAFMVE PIQGEAGVVV
     PDPGYLMGVR ELCTRHQVLF IADEIQTGLA RTGRWLAVDY ENVRPDIVLL GKALSGGLYP
     VSAVLCDDDI MLTIKPGEHG STYGGNPLGC RVAIAALEVL EEENLAENAD KLGIILRNEL
     MKLPSDVVTA VRGKGLLNAI VIKETKDWDA WKVCLRLRDN GLLAKPTHGD IIRFAPPLVI
     KEDELRESIE IINKTILSF
//
